Publications

Secondary to rising healthcare costs in the United States, broad efforts are underway to identify and reduce waste in the health system

The enactment of the Inflation Reduction Act (IRA) and the growth of state Prescription Drug Affordability Boards have raised important questions about how to improve drug affordability without curbing biopharmaceutical innovation

To determine how policymakers interact with bioethicists, their interest in future engagement, and their motivation and hesitations to do so

This paper contributes to the literature on structural modeling of online consumer search by incorporating both product position and social influence effects (e.g., product popularity) while allowing consumers to select multiple items per search and learn adaptively about their match with the platform.

The integration of generative artificial intelligence (AI) tools into healthcare poses significant challenges concerning data privacy and governance.

The integration of generative artificial intelligence (AI) tools into healthcare poses significant challenges concerning data privacy and governance. Drawing on the historical vignette of Henrietta Lacks, this perspective examines the implications of using generative AI in clinical settings. We discuss current health data governance practices and their potential limitations in the generative AI era. We propose a framework of proactive transparency to preserve patient autonomy without limiting technologic process.

Artificial intelligence (AI) is reshaping healthcare, promising improved diagnostics, personalized treatments, and streamlined operations.

Andrew Anderson, Mark Meiselbach and Kali Thomas for Health Affairs Forefront

Risa Wolf for Diabetes Spectrum

Melinda B. Buntin, and Angela Liu for JAMA Health Forum